DCVC Bio, L.P. — Form D/A
DCVC Bio, L.P. of PALO ALTO, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2019-05-14. The offering totals $250.0M, of which $208.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-05-14
- Form: D/A
- Accession: 0001735069-19-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $250.0M
- Amount sold: $208.0M
- Remaining: $42.0M
- Investors: 41
- Date of first sale: 2018-04-20
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-310630
Issuer
- Name: DCVC Bio, L.P.
- CIK: 0001735069
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 317 UNIVERSITY AVENUE, SUITE 200, PALO ALTO, CA, 94301
- Phone: 415-840-7337
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Zachary Bogue | Executive Officer | Palo Alto, CA |
| John Hamer | Executive Officer | Durham, NC |
| Matthew Ocko | Executive Officer | Palo Alto, CA |
| Kiersten Stead | Executive Officer | Palo Alto, CA |
Other filings by this issuer (1)
More